Allurion Technologies (NYSE:ALUR) is a medical device and digital health company that develops non-surgical solutions for weight management and obesity care. The company’s flagship product, the Elipse™ Gastric Balloon, is a swallowable, adjustable intragastric balloon designed to promote weight loss without the need for endoscopy or anesthesia. Complementing its devices, Allurion offers a cloud-based digital platform that enables healthcare providers to monitor patient progress in real time through connected scales and mobile applications.
In addition to its proprietary balloon system, Allurion delivers a comprehensive weight-management program that combines clinical nutrition counseling, behavioral coaching and data-driven insights. Patients enrolled in the Allurion pathway receive personalized guidance on diet and exercise, while clinicians leverage remote monitoring tools to track key health metrics such as weight, activity levels and compliance. The integration of medical devices with virtual care components supports scalable delivery of obesity treatment in both outpatient clinics and hospital settings.
Founded in 2009 and headquartered in Boston, Massachusetts, Allurion has expanded its operations to serve more than 20 countries across North America, Europe, Asia and the Middle East. The company collaborates with a global network of physicians, bariatric surgeons and weight-loss clinics to bring minimally invasive therapies to diverse patient populations. Allurion’s research and development efforts focus on advancing intragastric technologies, refining digital health applications and demonstrating clinical outcomes in peer-reviewed studies.
Allurion is led by a multidisciplinary executive team with deep expertise in medical device innovation, digital therapeutics and obesity management. With a leadership group comprising engineers, clinicians and business strategists, the company is committed to transforming chronic disease care and improving long-term patient outcomes through integrated solutions that address both physiological and behavioral aspects of weight loss.
